XML 58 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-based Compensation (Details Textual) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Jan. 01, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 98,184    
Risk-free interest rate 2.10%    
Expected volatility 125.20%    
Dividend yield 0.00%    
Compensation cost not yet recognized $ 2,900,000    
Compensation cost not yet recognized, period for recognition (in years) 5 years 310 days    
Allocated share-based compensation expense $ 366,383 $ 393,471  
Non-employee Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 9,394    
Risk-free interest rate 2.40%    
Expected volatility 136.40%    
Dividend yield 0.00%    
Fair value of options vested in period $ 53,000 300,000  
Number of unvested options (in shares) 27,561    
Compensation cost not yet recognized $ 65,000    
Compensation cost not yet recognized, period for recognition (in years) 2 years 3 days    
Stock options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of options vested in period $ 200,000 $ 100,000  
Weighted average grant date fair value (in dollars per share) $ 2.08    
Unvested restricted stock awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation cost not yet recognized, period for recognition (in years) 1 year 2 months 12 days    
Unvested shares of restricted stock (in shares) 7,665    
Restricted stock vested in period (in shares) 1,533    
Allocated share-based compensation expense $ 3,000    
Compensation not yet recognized, restricted stock $ 15,000    
Restorgenex Corporation 2015 Equity Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of total shares eligible for plan reserve on an annual basis 4.00%    
Number of shares authorized (in shares)     413,825
Number of shares available for grant (in shares) 356,148